Live Tuesday 27th September 2016. Gain insights into T-cell expansion, viral vector production and scaling production of mesenchymal stem cells (MSCs) through the use of a functionally closed, automated, cell culture process.

Gain insights into T-cell expansion, viral vector production and scaling production of mesenchymal stem cells (MSCs) through the use of a functionally closed, automated, cell culture process.

Dr. Beltzer (Terumo BCT, CO, U.S.) will present a number of case studies to describe how process development and economic goals were achieved in both industry and academic settings.

Results include up to a 500-fold expansion of T-cells in 12 days, 40 percent reduction in cost of goods for an allogeneic cell therapy, and automated viral vector production with titers similar to flask-based processes.

Particular attention will be directed toward the process changes often needed to meet these goals. What will you learn?

New results of T-cell expansion using a hollow-fiber bioreactor system Techniques for scaling production of mesenchymal stem cells (MSCs) New approach to viral vector production Case studies on cost and labor savings achieved

Links:

https://www.regmednet.com/users/3641-regmednet/posts/11324-case-studies-scaling-cell-therapy-manufacturing

http://event.on24.com/wcc/r/1239019/E0F3ADDD409EF0A1FE33FC4DE614965E?partnerref=RMNeventp

Download Attachments: